{
  "symbol": "GPN",
  "year": 2024,
  "Period": "Q2",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": -0.2732,
    "outlook_sentiment": 0.2672,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.146
  },
  "top_positive": [
    {
      "sent": "The following table sets forth the computation of diluted weighted-average number of shares outstanding for the three and six months ended June\u00a030, 2024 and 2023: Three Months Ended Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 (in thousands) Basic weighted-average number of shares outstanding 254,748 260,827 255,837 261,965 Plus: Dilutive effect of stock options and other share-based awards 418 501 540 429 Diluted weighted-average number of shares outstanding 255,166 261,328 256,377 262,394 NOTE 13\u2014 SUPPLEMENTAL BALANCE SHEET INFORMATION Cash, cash equivalents and restricted cash Cash and cash equivalents include cash on hand and all liquid investments with a maturity of three months or less when purchased.",
      "score": 0.9723
    },
    {
      "sent": "The following table sets forth the computation of diluted weighted-average number of shares outstanding for the three and six months ended June\u00a030, 2024 and 2023: Three Months Ended Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 (in thousands) Basic weighted-average number of shares outstanding 254,748 260,827 255,837 261,965 Plus: Dilutive effect of stock options and other share-based awards 418 501 540 429 Diluted weighted-average number of shares outstanding 255,166 261,328 256,377 262,394 NOTE 13\u2014 SUPPLEMENTAL BALANCE SHEET INFORMATION Cash, cash equivalents and restricted cash Cash and cash equivalents include cash on hand and all liquid investments with a maturity of three months or less when purchased.",
      "score": 0.9723
    },
    {
      "sent": "ITEM 2 \u2014 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS (c) Purchases of Equity Securities by the Issuer and Affiliated Purchasers Information about the shares of our common stock that we repurchased during the quarter ended June\u00a030, 2024 is set forth below: Period Total Number of Shares Purchased (1) Approximate Average Price Paid per Share, excluding commission Total Number of Shares Purchased as Part of Publicly Announced Plan\nnd capital expenditures; statements we make regarding guidance and projected financial results for the year 2024; the effects of general economic conditions on our business; statements about the benefits of our acquisitions or divestitures, including future financial and operating results and the completion and expected timing of our acquisitions or completion of anticipated benefits or strategic or operational initiatives; our success and timing in developing and introducing new services and expanding our business; and other statements regarding our future financial performance and the company's plans, objectives, expectations and intentions.",
      "score": 0.9658
    }
  ],
  "top_negative": [
    {
      "sent": "Although we have not experienced significant exposure or adverse effects on our business and financial results to date, the extent to which these events could affect the global economy and our operations is difficult to predict at this time.",
      "score": -0.68
    },
    {
      "sent": "ITEM 3\u2014QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK For a discussion of our exposure to market risk,\u00a0refer\u00a0to Part II, Item 7A, \"Quantitative and Qualitative Disclosures About Market Risk,\" contained in our Annual Report on Form 10-K for the year ended December\u00a031, 2023.",
      "score": -0.6037
    },
    {
      "sent": "ITEM 3\u2014QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK For a discussion of our exposure to market risk,\u00a0refer\u00a0to Part II, Item 7A, \"Quantitative and Qualitative Disclosures About Market Risk,\" contained in our Annual Report on Form 10-K for the year ended December\u00a031, 2023.",
      "score": -0.6037
    }
  ],
  "forward_snippets": [
    "We are evaluating how the enhanced disclosure requirements of ASU 2023-09 will affect our presentation, and we will include the incremental disclosures upon the effective date.",
    "We are evaluating how the enhanced disclosure requirements of ASU 2023-07 will affect our presentation, and we will include the incremental disclosures upon the effective date.",
    "We expect that approximately $ 1.2 billion of the goodwill from this acquisition will be deductible for income tax purposes.",
    "We are evaluating how the enhanced disclosure requirements of ASU 2023-07 will affect our presentation, and we will include the incremental disclosures upon the effective date.",
    "We expect that approximately $ 1.2 billion of the goodwill from this acquisition will be deductible for income tax purposes."
  ],
  "curated_text": "Symbol: GPN. Year: 2024. Period: Q2. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: The following table sets forth the computation of diluted weighted-average number of shares outstanding for the three and six months ended June\u00a030, 2024 and 2023: Three Months Ended Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 (in thousands) Basic weighted-average number of shares outstanding 254,748 260,827 255,837 261,965 Plus: Dilutive effect of stock options and other share-based awards 418 501 540 429 Diluted weighted-average number of shares outstanding 255,166 261,328 256,377 262,394 NOTE 13\u2014 SUPPLEMENTAL BALANCE SHEET INFORMATION Cash, cash equivalents and restricted cash Cash and cash equivalents include cash on hand and all liquid investments with a maturity of three months or less when purchased. The following table sets forth the computation of diluted weighted-average number of shares outstanding for the three and six months ended June\u00a030, 2024 and 2023: Three Months Ended Six Months Ended June 30, 2024 June 30, 2023 June 30, 2024 June 30, 2023 (in thousands) Basic weighted-average number of shares outstanding 254,748 260,827 255,837 261,965 Plus: Dilutive effect of stock options and other share-based awards 418 501 540 429 Diluted weighted-average number of shares outstanding 255,166 261,328 256,377 262,394 NOTE 13\u2014 SUPPLEMENTAL BALANCE SHEET INFORMATION Cash, cash equivalents and restricted cash Cash and cash equivalents include cash on hand and all liquid investments with a maturity of three months or less when purchased. ITEM 2 \u2014 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS (c) Purchases of Equity Securities by the Issuer and Affiliated Purchasers Information about the shares of our common stock that we repurchased during the quarter ended June\u00a030, 2024 is set forth below: Period Total Number of Shares Purchased (1) Approximate Average Price Paid per Share, excluding commission Total Number of Shares Purchased as Part of Publicly Announced Plan\nnd capital expenditures; statements we make regarding guidance and projected financial results for the year 2024; the effects of general economic conditions on our business; statements about the benefits of our acquisitions or divestitures, including future financial and operating results and the completion and expected timing of our acquisitions or completion of anticipated benefits or strategic or operational initiatives; our success and timing in developing and introducing new services and expanding our business; and other statements regarding our future financial performance and the company's plans, objectives, expectations and intentions. Top negative sentences: Although we have not experienced significant exposure or adverse effects on our business and financial results to date, the extent to which these events could affect the global economy and our operations is difficult to predict at this time. ITEM 3\u2014QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK For a discussion of our exposure to market risk,\u00a0refer\u00a0to Part II, Item 7A, \"Quantitative and Qualitative Disclosures About Market Risk,\" contained in our Annual Report on Form 10-K for the year ended December\u00a031, 2023. ITEM 3\u2014QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK For a discussion of our exposure to market risk,\u00a0refer\u00a0to Part II, Item 7A, \"Quantitative and Qualitative Disclosures About Market Risk,\" contained in our Annual Report on Form 10-K for the year ended December\u00a031, 2023. Forward-looking snippets: We are evaluating how the enhanced disclosure requirements of ASU 2023-09 will affect our presentation, and we will include the incremental disclosures upon the effective date. We are evaluating how the enhanced disclosure requirements of ASU 2023-07 will affect our presentation, and we will include the incremental disclosures upon the effective date. We expect that approximately $ 1.2 billion of the goodwill from this acquisition will be deductible for income tax purposes. We are evaluating how the enhanced disclosure requirements of ASU 2023-07 will affect our presentation, and we will include the incremental disclosures upon the effective date. We expect that approximately $ 1.2 billion of the goodwill from this acquisition will be deductible for income tax purposes."
}